Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
1220 RESULTS FOUND
Antitrust Guidelines for AdvaMed Activities
June 8, 2020 | Guidance
Code of Ethics Compliance Guidance Related to the COVID-19 Response
May 6, 2020 | Guidance
AdvaMedDx COVID-19 Testing Infographic
May 5, 2020 | Infographic
COVID-19 Ethics Statement
April 29, 2020 | Statement
AdvaMed Request for Tariff Exclusions for Medical Technology Products
April 29, 2020 | Letter
ABHI – AdvaMed Memorandum of Understanding Regarding Cooperation and Collaboration
April 29, 2020 |
AdvaMed Code of Ethics 2020 (Portuguese)
April 27, 2020 | Guidance
AdvaMed Code of Ethics 2020 (Spanish)
April 27, 2020 | Guidance
AdvaMedDx COVID-19 Test Q&A
April 24, 2020 | FAQs
Creating and Implementing a Covid-19 Return-to-Work Plan webinar - April 22, 2020
April 22, 2020 | Presentation
COVID-19 Toolkit
April 20, 2020 |
Accel COVID19 Webpage - 200410_Coalition_PPPAffiliationRules_Fed_Treasury_SBA
April 13, 2020 | Letter
Accel Weekly Policy Call - April Payment - Non-emergent procedures CARES letter
April 10, 2020 | Letter
Accel COVID19 webpage - 2020-04-03 AdvaMed Letter to Treasury & SBA (SBA Affiliation Rules)
April 3, 2020 | Letter
Summary of Selected Provisions of the Defense Production Act
March 27, 2020 |
The Defense Production Act (DPA) and COVID-19: Key Authorities and Policy Considerations
March 27, 2020 |
HR 748 - Coronavirus Aid, Relief, and Economic Security Act
March 26, 2020 |
CARES Act Resources for Workers and Families
March 26, 2020 |
AdvaMed Recommendation to Centralize Procurement and Allocation Decision-making of Ventilators
March 24, 2020 | Comments
AdvaMed Accel 2019 Achievements
March 13, 2020 |
AdvaMed Comments on Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters-Premarket Notification [(510(k)] Submissions
March 12, 2020 | Comments
Letter of Appreciation from the Shanghai Municipal Government
March 10, 2020 | Comments
AdvaMed Comment on CMS’ NCA on Artificial Hearts and Related Devices
March 4, 2020 | Letter
ESRD Letter
February 21, 2020 | Letter
AdvaMed Comments on National Emission Standards for Hazardous Air Pollutants: Miscellaneous Organic Chemical Manufacturing Residual Risk and Technology Review
February 19, 2020 | Comments

Pages